Evidence map›Paper›PMID 37898793›Full record

ArticleDiagnostic pathology2023

Penile melanoma: a pathological report of two cases.

Boglárka Pósfai, Márton Szentkereszty, Fanni Sánta, Zoltán Bajory, Andrea Simon, Zsófia Kozéki, Ildikó Csányi, Mahmut Akgul, Levente Kuthi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Boglárka Pósfai *Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Állomás utca 1., Szeged, H-6725, Hungary.
Márton Szentkereszty *Tumor Pathology Center, National Institute of Oncology, Budapest, Hungary.
Fanni SántaDepartment of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Állomás utca 1., Szeged, H-6725, Hungary.
Zoltán BajoryDepartment of Urology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Andrea SimonTumor Pathology Center, National Institute of Oncology, Budapest, Hungary.
Zsófia KozékiDepartment of Dermatology, National Institute of Oncology, Budapest, Hungary.
Ildikó CsányiDepartment of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Mahmut AkgulDepartment of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY, USA.
Levente KuthiDepartment of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Állomás utca 1., Szeged, H-6725, Hungary. kuthi.levente@med.u-szeged.hu.
University of Szeged · HUNational Institute of Oncology · HUAlbany Medical Center Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPenile melanoma (PM) is a rare tumor, accounting for less than 2% of all penile cancers. PM can occur on the surface of the glans, foreskin, and opening of the urethra. Furthermore, PM primarily affects older individuals and is not associated with sun exposure. Currently, there is no specific staging system for genitourinary tract melanomas, so these tumors are typically staged using the criteria for cutaneous melanoma. Limited data in the literature suggests that PM generally has a poor clinical prognosis. CASE PRESENTATION: Here, we describe two cases of PM. The first case affected a 62-year-old male who presented with hematuria and a painful tumor in the distal urethra, leading to a suspicion of penile cancer. The second case involved a 68-year-old male who noticed a rapidly evolving dark spot on his foreskin. Histological analysis confirmed the presence of melanoma in both patients. The tumors showed a diffuse and strong PRAME-positivity and lacked BRAF mutation in both cases. Additionally, the second tumor harbored an activating CKIT mutation. An enhanced PD-L1 expression was observed in both tumors.

conclusionsWe presented two rare forms of mucosal melanoma and highlighted the entities in the differential diagnosis. Based on our experience PRAME is a helpful marker for making the diagnosis of PM, and PD-L1 can predict the success of the immunotherapy. We also emphasize the need for an organ-specific staging system for PMs.

Indexed as

MelanomaPenile NeoplasmsSkin NeoplasmsAgedAntigens, NeoplasmB7-H1 AntigenHumansMaleMiddle AgedAntigens, NeoplasmB7-H1 AntigenPRAME protein, humanMelanomaMucosal MelanomaPRAMEStaging

Identifiers

PMID37898793
PMCPMC10613369
OpenAlexW4388000295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.